Annual report pursuant to Section 13 and 15(d)

Licensing Arrangements (Details Narrative)

v3.24.1
Licensing Arrangements (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Apr. 26, 2022
Dec. 31, 2023
Dec. 31, 2022
Offsetting Assets [Line Items]      
Research and development costs   $ 3,494,765 $ 4,770,834
CLS [Member]      
Offsetting Assets [Line Items]      
Ownership percentage   9.60%  
Sublicense And License Agreements [Member]      
Offsetting Assets [Line Items]      
Common shares issued 87,500    
Total consideration $ 1,300,000    
Cash payment     500,000
Number of shares purchase of asset, value $ 800,000    
Research and development costs     1,300,000
Volition [Member]      
Offsetting Assets [Line Items]      
Research and development costs   $ 100,000  
Patent Assignment [Member]      
Offsetting Assets [Line Items]      
Research and development costs     500,000
D Nase Technology [Member] | CLS [Member]      
Offsetting Assets [Line Items]      
Consulting, transaction and development costs     $ 400,000
Sublicense Agreement Shares [Member] | CLS [Member]      
Offsetting Assets [Line Items]      
Common shares issued 37,500    
Sublicense And License Agreements [Member] | CLS [Member]      
Offsetting Assets [Line Items]      
Common shares issued 50,000    
One-time fee $ 500,000